Discusses Positive Phase 3 PEAK Trial Results of Bezuclastinib in Gastrointestinal Stromal Tumors November 8:00 ...
After a year of boardroom declarations about “AI transformation,” this was the week where enterprise leaders came together to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback